Cingulate (CINGW) Competitors $0.04 0.00 (-9.52%) As of 11:40 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock CINGW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Cingulate vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity 180 Life Sciences (NASDAQ:ATNFW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, community ranking, valuation, earnings and institutional ownership. Does the MarketBeat Community believe in ATNFW or CINGW? 180 Life Sciences and Cingulate both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACingulateN/AN/A Does the media refer more to ATNFW or CINGW? In the previous week, 180 Life Sciences had 1 more articles in the media than Cingulate. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for Cingulate. Cingulate's average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.24 indicating that Cingulate is being referred to more favorably in the news media. Company Overall Sentiment 180 Life Sciences Positive Cingulate Very Positive Which has stronger valuation and earnings, ATNFW or CINGW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACingulateN/AN/AN/AN/AN/A Is ATNFW or CINGW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Cingulate N/A N/A N/A Summary180 Life Sciences and Cingulate tied by winning 1 of the 2 factors compared between the two stocks. Get Cingulate News Delivered to You Automatically Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CINGW vs. The Competition Export to ExcelMetricCingulateBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$124.09M$5.49B$7.95BDividend YieldN/A3.69%5.11%4.22%P/E RatioN/A3.2022.6218.58Price / SalesN/A4,245.92397.85103.49Price / CashN/A13.0238.1834.62Price / BookN/A33.726.744.25Net IncomeN/A-$90.45M$3.22B$248.18M7 Day PerformanceN/A4.11%1.59%1.36%1 Month PerformanceN/A5.53%4.09%3.85%1 Year PerformanceN/A94.32%15.98%5.37% Cingulate Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CINGWCingulateN/A$0.04-9.5%N/A+90.9%$0.00N/A0.0020Positive NewsGap DownATNFW180 Life SciencesN/A$0.01flatN/A-11.8%$0.00N/A0.007News CoveragePositive NewsLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.03+9.1%N/AN/A$0.00N/A0.002Gap UpHigh Trading VolumeAIMDWAinosN/A$0.11+24.0%N/AN/A$0.00$20,729.000.0040Positive NewsALVOWAlvotechN/A$1.40+26.1%N/A-59.3%$0.00$489.68M0.004Short Interest ↑News CoverageGap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03flatN/A-76.3%$0.00N/A0.0015Gap DownBFRIWBiofronteraN/A$0.05-29.5%N/AN/A$0.00$37.32M0.0070Positive NewsBTMDWbioteN/A$0.01-2.3%N/A-89.9%$0.00$197.19M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.14+7.8%N/A-86.8%$0.00N/A0.008Gap UpCELUWCelularityN/A$0.04-3.3%N/A+14.0%$0.00$48.20M0.00220Positive NewsGap Down Related Companies and Tools Related Companies ATNFW Competitors LBPSW Competitors AEHAW Competitors AIMDW Competitors ALVOW Competitors ACABW Competitors BFRIW Competitors BTMDW Competitors BCTXW Competitors CELUW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CINGW) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cingulate Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cingulate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CINGW Stock Free CINGW Stock Alerts